SCHEMBL493425

SCHEMBL493425

CN(CCOCC(=O)NCC1CCC(C(c2ccccc2)N2CCOCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.37
THRB P10828 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NAPEPLD Q6IQ20 4/20 0.36
CACNA2D1 P54289 1/20 0.35
CACNA1B Q00975 1/20 0.35
CACNB1 Q02641 1/20 0.35
CACNA1C Q13936 1/20 0.35
PTGIR P43119 1/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
BDKRB1 P46663 1/20 0.35
FAAH O00519 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TRPV4 Q9HBA0 1/20 0.34
GALR3 O60755 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492927 0.94 CACNA2D1 (0.36) MEN1KMT2ACACNA2D1CACNA1BCACNB1
SCHEMBL492623 0.92 NAPEPLD (0.36) CNR2THRBMEN1KMT2ANAPEPLD
SCHEMBL492771 0.90 MEN1 (0.38) CNR2THRBMEN1KMT2ACACNA2D1
SCHEMBL493578 0.89 NAPEPLD (0.37) THRBMEN1KMT2ANAPEPLDCACNA2D1
SCHEMBL493473 0.88 NAPEPLD (0.37) CNR2MEN1KMT2ANAPEPLDFAAH
SCHEMBL493208 0.86 GRM5 (0.37) NAPEPLDPTGIRBDKRB1FAAHBCHE
SCHEMBL493688 0.85 PTGIR (0.37) MEN1KMT2ACACNA2D1CACNA1BCACNB1
SCHEMBL493689 0.83 CACNA2D1 (0.37) CNR2MEN1KMT2ACACNA2D1CACNA1B
SCHEMBL493034 0.83 BDKRB1 (0.49) BDKRB1
SCHEMBL493359 0.82 BDKRB1 (0.36) CNR2PTGIRBDKRB1LMNATRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD CNR2 24/4885THRB 3770/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.